Trial intelligence / Profile preview

Alternate Day Buprenorphine Administration Phase IX

NCT00000232Phase 2Completed

Sponsor
The University of Vermont
Start
Mar 1992
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of buprenorphine in opioid use disorder (OUD), sponsored by The University of Vermont. Started Mar 1992; status: completed.

02

Drugs

buprenorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00000232.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000232.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call